港股異動丨新秀麗(1910.HK)大漲8.54% 獲大行唱多
格隆匯6月8日丨新秀麗(1910.HK)大漲8.54%,報17.8港元,高見17.94港元創近五個半月新高,最新總市值255億港元。新秀麗與若干貸款人及金融機構訂立了信貸協議的進一步修訂協議,倘於2021年9月30日直至2022年3月31日止期間,集團選擇採用歷史EBITDA以計算經修訂信貸協議的財務契諾項下之最高總淨槓桿比率及最低利息保障比率,則截至2020年12月31日、2021年3月31日及2021年6月30日止每個季度的歷史EBITDA將獲調高相等於6574.95萬美元的加回金額。於修訂協議的同時,集團已償還其優先有抵押A定期貸款融通項下的未償還借款的本金額1.25億美元,亦已主動償還其循環信貸融通項下的未償還借款的本金額1億美元。另外,新秀麗獲匯豐證券將新秀麗評級上調至“買入”,目標價22港元。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.